NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
批准号:
6290749
负责人:
JAMES B MITCHELL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Rodentias analog chemical structure function cytotoxicity drug screening /evaluation electron spin resonance spectroscopy free radical scavengers hydrogen peroxide ionizing radiation laboratory mouse neoplastic cell nitrogen oxides oxidation reduction reaction oxidative stress oxidizing agents radiation protection radioprotective agents superoxide dismutase superoxides tissue /cell culture
中文摘要
用作EPR自旋标记的氮氧化物(如tempol)已被证明具有超氧化物歧化酶(SOD)活性,并且在保护细胞免受各种氧化应激(包括过氧化氢、超氧化物、有机氢过氧化物、氧化还原循环化疗药物和电离辐射)方面非常有效。我们已经证明,Tempol可以保护体外细胞和小鼠免受电离辐射。因此,氮氧化物代表了一类新的辐射保护剂,可以广泛用于保护人类免受辐射。重要的是,我们已经证明tempol不能保护啮齿动物的肿瘤组织;我们认为其机制涉及正常组织与肿瘤组织的差异代谢减少特性。携带肿瘤的动物模型的体内电子顺磁共振成像研究表明,与正常组织相比,肿瘤中氮氧化物的减少速度更快。我们已经完成了一项体外研究,以确定最有效的保护目的的氮氧化物。对110多种氮氧化物进行了构效关系研究。我们已经确定了6种氮氧化物,它们比tempol(第一种显示出具有辐射防护特性的氮氧化物)提供更强的辐射防护能力,并且还确定了3种类似物,它们对有氧细胞具有辐射敏化作用。这些药物将在体内进行评估和与tempol进行比较。为了进一步研究这些新发现的保护剂,正在大量合成六种保护性氮氧化物中的几种。我们最近表明,血红素蛋白暴露于氧化剂形成高毒性铁基部分,氮氧化物解毒这些有毒物种,并赋予血红素物种增强过氧化氢酶样活性。以类似的方式推理,我们正在研究氮氧化物作为一氧化氮合酶调节剂的影响,因为酶内依赖血红素氧化还原化学的中间体在氮氧化物的存在下可能被改变。我们还在体内模型中研究附着在大分子(如白蛋白)上的氮氧化物的活性。由于这些药物很容易穿透细胞膜,它们可能用于其他医学研究领域,如缺血/再灌注损伤研究、预防白内障、炎症过程和衰老。用作电子顺磁共振(EPR)自旋标记的氮氧化物(如tempol)已被证明具有超氧化物歧化酶(SOD)活性,并且在保护细胞免受各种氧化应激(包括过氧化氢、超氧化物、有机氢过氧化物、氧化还原循环化疗药物和电离辐射)方面非常有效。我们已经证明,tempol可以保护体外细胞和小鼠免受电离辐射。对动物施用时不影响血压的不同氮氧化物类似物已被确定为放射性保护剂,从而消除了tempol给药对血流动力学的影响。最近的研究表明,tempol不能保护啮齿动物的肿瘤组织;我们认为其机制涉及正常组织与肿瘤组织的差异代谢减少特性。一种荷瘤动物模型的体内EPR成像研究显示,与正常组织相比,肿瘤中氮氧化物的减少速度更快。目前,我们正在利用我们新构建的小动物功能性EPR成像仪器,寻找和定义导致这种差异效应的细胞和生理因素。最近的研究表明,缺乏葡萄糖6磷酸脱氢酶(G6PD)的细胞将氮氧化物还原为羟胺的速度比对照细胞慢得多,这表明这一重要的生化途径在氮氧化物还原中的作用。我们目前正在研究G6PD在肿瘤和正常组织中的状态。使用氮氧化物自旋探针,功能性EPR成像系统还将使我们能够绘制组织中的氧水平以及研究组织的各种氧化还原参数。目前正在进行研究,评估局部应用于大鼠直肠的tempol的辐射防护性能。由于直肠是前列腺癌和/或宫颈癌患者放疗期间受损的主要正常组织,如果我们的临床前研究证明是阳性的,我们将考虑在临床上使用tempol来保护直肠。我们目前的研究是针对氮氧化物输送到直肠组织的方法,以优化氮氧化物浓度。初步研究表明,对p53基因敲除小鼠长期给予tempol(在食物或饮用水中)可延长其寿命。P53基因敲除小鼠在出生几个月后因肿瘤快速诱导死亡。给药后寿命延长35 ~ 70%。这种作用的机制是未知的,目前是一个主要的焦点。最后,由于这些药物很容易穿透细胞膜,是有效的抗氧化剂,它们可能用于其他医学研究领域,如缺血/再灌注损伤研究,预防白内障,炎症过程和衰老。最近有研究表明,大鼠脑缺血后给药tempol可显著减少缺血/再灌注相关的梗死体积。
英文摘要
Nitroxides (such as tempol) which have been used as EPR spin labels have been shown to exhibit superoxide dismutase (SOD) activity and are quite effective agents in protecting cells against a wide variety of oxidative stresses including hydrogen peroxide, superoxide, organic hydroperoxides, redox-cycling chemotherapy drugs, and ionizing radiation. We have demonstrated that Tempol protects both cells in vitro and mice against ionizing radiation. Thus, the nitroxides represent a new class of radiation protectors that may have widespread use in protecting humans against radiation. Importantly, we have shown that tempol does not protect rodent tumor tissue; the mechanism of which we believe involves differential metabolic reduction properties of normal versus tumor tissue. In vivo electron paramagnetic resonance imaging studies in a tumor-bearing animal model has shown more rapid reduction of nitroxides in tumor compared to normal tissue. We have completed an in vitro study to identify the most efficient nitroxide for protection purposes. Over 110 nitroxides were evaluated in a structure activity relationship study. We have identified 6 nitroxides that afford significantly more radioprotection than tempol (the first nitroxide shown to have radioprotective properties) and have also identified 3 analogs that radiosensitize aerobic cells. These agents will be evaluated and compared with tempol in vivo. Large quantities of several of the six protective nitroxides are being synthesized for further study of these newly discovered protectors. We have recently shown that heme proteins exposed to oxidants form highly toxic ferryl moieties and that nitroxides detoxify these toxic species and confer enhanced catalase-like activity to heme species. Reasoning in an analogous fashion we are investigating the affects of nitroxides as modulators of nitric oxide synthase because intermediates within the enzyme which depend on heme redox chemistry may be altered in the presence of nitroxides. We are also investigating in in vivo models, the activity of nitroxides appended to macromolecules such as albumin. Since these agents readily penetrate cell membranes, they may be of use in other areas of medical research such as ischemia/reperfusion injury studies, prevention of cataracts, inflammatory processes and aging. Nitroxides (such as tempol) which have been used as electron paramagnetic resonance (EPR) spin labels have been shown to exhibit superoxide dismutase (SOD) activity and are quite effective agents in protecting cells against a wide variety of oxidative stresses including hydrogen peroxide, superoxide, organic hydroperoxides, redox-cycling chemotherapy drugs, and ionizing radiation. We have demonstrated that tempol protects both cells in vitro and mice against ionizing radiation. Different nitroxides analogues that do not influence blood pressure when administered to animals have been positively identified as radioprotectors thus eliminating the hemodynamic concerns of tempol administration. Recent studies have shown that tempol does not protect rodent tumor tissue; the mechanism of which we believe involves differential metabolic reduction properties of normal versus tumor tissue. In vivo EPR imaging studies in one tumor-bearing animal model has shown more rapid reduction of nitroxides in tumor compared to normal tissue. We are presently seeking to identify and define cellular and physiological factors responsible for this differential effect using our newly constructed functional EPR imaging instrumentation for small animals. Recent studies have shown that cells deficient in glucose 6 phosphate dehydrogenase (G6PD) reduce the nitroxide to the hydroxylamine much slower than control cells suggesting a role for this important biochemical pathway in nitroxide reduction. We are presently studying G6PD status in tumor versus normal tissue. Using nitroxide spin probes, the functional EPR imaging system will also enable us to map out oxygen levels in tissue as well as study various redox parameters of tissue.Studies are presently underway evaluating the radioprotective properties of tempol applied topically to the rectum of rats. Since the rectum is a major normal tissue damaged during radiotherapy for patients with prostate and/or cervix cancer, we will consider using tempol clinically to protect the rectum should our pre-clinical studies prove positive. Our present studies are directed on nitroxide delivery methods to rectal tissue to optimize nitroxide concentration.Preliminary studies have indicated that long term administration of tempol (in the food or drinking water) to p53 knockout mice extends their life span. p53 knockout mice die several months after birth due to rapid tumor induction. Tempol administration extended the life span of these animals ~35-70%. The mechanism of this effect is unknown and is presently a major focus. Lastly, since these agents readily penetrate cell membranes and are potent antioxidants, they may be of use in other areas of medical research such as ischemia/reperfusion injury studies, prevention of cataracts, inflammatory processes, and aging. It has recently been shown that tempol administration after induced ischemia of rat brain markedly reduced the infarct volume associated with ischemia/reperfusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Therapeutic Response
-
批准号:6947107
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Radiolysis, Photolysis, Sonolysis and Sonoprotection of
-
批准号:7331390
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7594762
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7292012
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7292006
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7331383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7594757
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7735357
-
项目类别:
-
资助金额:$44.88万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6558297
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6558332
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7066825
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6756256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6433342
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6756263
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7735362
-
项目类别:
-
资助金额:$44.88万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6433348
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
MODULATION OF THERAPEUTIC RESPONSE
-
批准号:6290743
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
海外基金